APRIL knockdown suppresses migration and invasion of human colon carcinoma cells

Weifeng Ding1, Jinchun Wang, Baolan Sun

  • 1Medical Laboratory Center, Affiliated Hospital of Nantong University, No. 20 Road Xisi, Nantong, Jiangsu, PR China.

Abstract

Insights

Proliferation-inducing ligand (APRIL) promotes colorectal cancer (CRC) cell migration and invasion. Inhibiting APRIL reduces CRC cell adhesion, migration, and invasion, suggesting APRIL as a therapeutic target for colon carcinomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastatic colorectal cancer (CRC) poses a significant health challenge.
  • Understanding the molecular mechanisms driving CRC progression is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of proliferation-inducing ligand (APRIL) in the development of metastatic colorectal cancer (CRC).
  • To determine if APRIL influences key cellular behaviors associated with cancer metastasis.

Main Methods:

  • Knockdown of APRIL expression in the SW480 colon carcinoma cell line using RNA interference (RNAi).
  • Assessment of cell adhesion, migration, and invasion following APRIL knockdown.
  • Rescue experiments using recombinant human APRIL (rhAPRIL) to restore APRIL expression in knockdown cells.

Main Results:

  • APRIL gene knockdown significantly inhibited colon carcinoma cell adhesion, migration, and invasion in vitro.
  • Reintroduction of APRIL using rhAPRIL in knockdown cells restored CRC cell migration and invasion capabilities.
  • These findings highlight APRIL's direct impact on invasive phenotypes of CRC cells.

Conclusions:

  • APRIL plays a critical role in promoting tumor development by enhancing the invasive and migratory behavior of colorectal cancer cells.
  • APRIL represents a potential therapeutic target for treating malignant colon carcinomas.
  • Targeting APRIL could offer a novel strategy to combat CRC metastasis.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...